Draft legislation has emerged that ostensibly would boost rapid innovation to combat the coronavirus. Bottom line: The bill is a mixed bag with a lot of questions… The Facilitating Innovation to Fight Coronavirus Act appears to be an attempt to bring any and all viable medical inventions to bear, as quickly as possible, in our fight to defeat COVID-19, which is absolutely to be commended. Despite attempts to mitigate the harm that outright eminent domain on patent rights (vigorously advocated by some) would certainly cause, the legislation needs more work.
Recent Posts
- IP News: Barks & Bites for Friday, March 21 | IPWatchdog
- The Outlook for SEPs in 2025: Anti-Suit Injunctions, DOJ Policy and GenAI
- Can State Law Contracts Limit the Right to Repair Even When Patent Protections Exhaust?
- Scarcity or Abundance Mindset? How Scarcity-Minded Leaders Undermine Team Culture and Potential
- ParkerVision v. Rule 36 | Patently Strategic Podcast